Cite

HARVARD Citation

    Xu, X. et al. (2020). Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer. Bioengineered. 11 (1), pp. 1170-1188. [Online]. 
  
Back to record